Susceptibility genes and overall pathogenesis of inflammatory bowel disease: Where do we stand?

Digestive Diseases

Volumn 27, Issue 3, 2009, Pages 226-235

  Fiocchi, Claudio ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

APOPTOSIS; AUTOPHAGY; CONFERENCE PAPER; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERITIS; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HLA SYSTEM; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; ULCERATIVE COLITIS;

APOPTOSIS; AUTOPHAGY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE ACTIVATION;

EID: 70349930153     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228554     Document Type: Conference Paper

References (85)

1. Editorial: Crohn's disease. Lancet 1976;ii: 1284-1285.
2. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994; 265: 2037-2048.
3. Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429.
4. Xavier RJ, Podolsky D: Unraveling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434. (Pubitemid 47123518)
5. Scaldaferri F, Fiocchi C: Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis 2007; 8: 171-178.
6. Danese S, Sans M, Fiocchi C: Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004; 3: 390-400. (Pubitemid 38993362)
7. Chakravarti A, Little P: Nature, nurture and human disease. Nature 2003; 421: 412-414.
8. Asquith P, Stokes PL, Mackintosh P, Holmes GKT, Cooke WT: Histocompatibility antigens in patients with inflammatory bowel disease. Lancet 1974;i:113-115.
9. Asakura H, Tsuchiya M, Aiso S, Watanabe M, Kokayashi K, Hibi T, Ando K, Takata H, Sekiguchi S: Association of the human lymphocyte- DR2 antigen with Japanese ulcerative colitis. Gastroenterology 1982; 82: 413-418. (Pubitemid 12166803)
10. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, Jewell DP: Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347: 1212-1217. (Pubitemid 26131848)
11. Tountas NA, Casini-Raggi V, Yang H, Di Giovane FS, Vecchi M, Kam L, Melani L, Pizarro TT, Rotter JI, Cominelli F: Functional and ethnic association of allele 2 of the interleukin- 1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999; 117: 806-813. (Pubitemid 29468222)
12. Cardon LR: Delivering new disease genes. Science 2006; 314: 1403-1405.
13. Donnelly P: Progress and challenges in genome- wide association studies in humans. Nature 2008; 456: 728-731.
14. Cho JH, Weaver CT: The genetics of inflammatory bowel disease. Gastroenterology 2007; 133: 1327-1339.
15. Cho JH: The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev 2008; 8: 458-466. (Pubitemid 351733422)
16. Van Limbergen J, Russell RK, Nimmo ER, Ho G-T, Arnott ID, Wilson DC, Satsangi J: Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 338-355. (Pubitemid 46465916)
17. Duerr RH: Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology 2007; 132: 2045-2062.
18. Massey D, Parkes M: Common pathways in Crohn's disease and other inflammatory diseases revealed by genomics. Gut 2007; 56: 1489-1492. (Pubitemid 350033180)
19. Dubois PC, van Heel DA: New susceptibility genes for ulcerative colitis. Nat Genet 2008; 6: 686-688.
20. Brant SR: Exposed: the genetic underpinnings of ulcerative colitis relative to Crohn's disease. Gastroenterology 2009; 136: 396-399.
21. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonatti- Pellie C, Weissenbach J, Methew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G: Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-823. (Pubitemid 26067722)
22. Hugot JP, Chamaiilard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603. (Pubitemid 32531408)
23. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G: Nod2, a Nod1-Apaf-1 family member that is restricted to monocytes and activates NF-κB. J Biol Chem 2001; 276: 4812-4818. (Pubitemid 37371366)
24. Sartor RB: Intestinal microflora in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol 2001; 4: 324-330. (Pubitemid 32619973)
25. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ: Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-8872. (Pubitemid 36800360)
26. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamurai S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G: Host recognition of bacterial muramyl dipeptide mediated through NOD2. J Biol Chem 2003; 278: 5509-5512.
27. Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, Chen FF, Foster SJ, Duerr RH, Brant SR, Cho JH, Nunez G: Crohn's disease- associated NOD2 variants share a signaling defect in response to lipolysaccharide and peptidoglycan. Gastroenterology 2003; 124: 140-146. (Pubitemid 36055347)
28. Li J, Moran T, Swanson E, Julian C, Harris J, Bonen DK, Hedi M, Nicolae DL, Abraham C, Cho JH: Regulation of IL-8 and IL-1β expression in Crohn's disease associated with NOD2/CARD15 mutations. Hum Mol Genet 2004; 13: 1715-1725. (Pubitemid 39173441)
29. Kramer M, Netea MG, de Jong DJ, Kullberg BJ, Adema GJ: Impaired dendritic cell function in Crohn's disease pateints with NOD2 3020insC mutation. J Leukoc Biol 2006; 79: 860-866. (Pubitemid 44835619)
30. Abreu MT, Taylor KD, Ling YC, Hang T, Gaiennie J, Landers CJ, Vasiliauskas EA, Kam LY, Rojany M, Papadakis KA, Rotter JI, Targan SR, Yang H: Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002; 123: 679-688. (Pubitemid 34977073)
31. Eckmann L, Karin M: NOD2 and Crohn's disease: loss or gain of function? Immunity 2005; 22: 661-667.
32. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638.
33. Turnbaugh PJ, Ley RE, Hamady M, Fraser- Liggett CM, Knoight R, Gordon JI: The human microbiome project. Nature 2007; 449: 804-810.
34. Sartor RB: Microbial influences in inflammatory bowel disease. Gastroenterology 2008; 134: 577-594. (Pubitemid 351173057)
35. Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136: 65-80.
36. Medzhitov R: Recognition of microorganisms and activation of the immune response. Nature 2007; 449: 819-826. (Pubitemid 47598622)
37. Ouellette AJ: Paneth cells and innate immunity in the crypt microenvironment. Gastroenterology 1997; 113: 1779-1784.
38. Creagh EM, O'Neill LAJ: TLRs, NLRs and RLRs: a trinity of pathogen sensors that cooperate in innate immunity. Trends Immunol 2006; 27: 352-357.
39. Barton GM: A calculated response: control of inflammation by the innate immune system. J Clin Invest 2008; 118: 413-420.
40. Marks DJB, Hardbord MWN, MacAllister R, Rahman F, Young J, Al-Lazikani B, Lees W, Novelli M, Bloom S, Segal AW: Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006; 367: 668-678. (Pubitemid 43289157)
41. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF: High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412-421.
42. Prantera C: Mycobacteria and Crohn's disease: the endless story. Dig Liver Dis 2007; 39: 452-454.
43. Ferwerda G, Kullberg BJ, de Jong DJ, Girardin SE, Langenberg DML, van Crevel R, Ottehoff THM, Van der Meer JWM, Netea MG: Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J Leukoc Biol 2007; 82: 1011-1018.
44. Mucha R, Bhide MR, Chakurkar EB, Novak M, Mikula I: Toll-like receptors TLR1, TLR2 and TLR4 gene mutations and natural resistance to Mycobacterium avium subsp. paratuberculosis infection in cattle. Vet Immunol Immunopathol 2009; 128: 381-388.
45. De Jager PL, Franchimont D, Waliszewska A, et al: The role of the Toll receptor pathway in susceptibility to inflammatory bowel disease. Genes Immun 2007; 8: 387-397. (Pubitemid 47163102)
46. Fellermann K, Wehkamp J, Herrlinger KR, Stange EF: Crohn's disease: a defensin deficiency syndrome? Eur J Gastroenterol Hepatol 2003; 15: 627-634.
47. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F, Fritz P, Schroder JM, Bevins CL, Fellermann K, Stange EF: NOD2(CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 2004; 53: 1658-1664. (Pubitemid 39434112)
48. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichental M, Petras RE, Shen B, Schaffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H, Fellermann K, Ganz T, Stange EF, Bevins CL: Reduced Paneth cell α-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 2005; 102: 18129-18134. (Pubitemid 41798513)
49. Hampe H, Franke A, Rosenstiel P, et al: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207-211. (Pubitemid 46184351)
50. Rioux JD, Xavier RJ, Taylor KD, et al: Genome- wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39: 596-604.
51. Parkes M, Barrett JC, Prescott NJ, et al: Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007; 39: 830-832. (Pubitemid 47014496)
52. Yano T, Kurata S: An unexpected twist for autophagy in Crohn's disease. Nat Immunol 2009; 10: 134-136.
53. Singh SB, Davis AS, Taylor GA, Deretic V: Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006; 313: 1438-1441.
54. Nedjic J, Aichinger A, Emmerich J, Mizushima N, Klein L: Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 2008; 455: 396-401.
55. Maiuri MC, Zalxkvar E, Kimchi A, Kroemer G: Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-752. (Pubitemid 47312826)
56. Sturm A, Fiocchi C: Life and death in the gut: more killing, less Crohn's. Gut 2002; 50: 148-149. (Pubitemid 34087922)
57. Yamazaki K, McGovern D, Ragoussis J: Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2007; 14: 3499-3506.
58. Kugathasan S, Baldassano RN, Bradfield JP, et al: Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 2008; 40: 1211-1215.
59. Boirivant M, Marini M, Di Felice G, Pronio AM, Montesani C, Tersigni R, Strober W: Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999; 116: 557-565. (Pubitemid 29106763)
60. Ina K, Itoh J, Fukushima K, et al: Resistance of Crohn's disease T-cells to multiple apoptotic stimuli is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 1999; 163: 1081-1090. (Pubitemid 29328123)
61. Duerr RH, Taylor KD, Brant SR, et al: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463. (Pubitemid 44871953)
62. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-673.
63. Brombacher F, Kastelein RA, Alber G: Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 2003; 24: 207-212. (Pubitemid 36412109)
64. Iwakura Y, Ishigame H: The IL-23/IL-17 axis in inflammation. J Clin Invest 2006; 116: 1218-1222.
65. McKenzie BS, Kastelein RA, Cua DJ: Understanding the IL-23/IL-17 immune pathway. Trends Immunol 2006; 27: 17-23.
66. Monteleone G, MacDonald TT, Wathen NC, Pallone F, Pender SLF: Enhancing lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury. Gastroenterology 1999; 117: 1069-1077. (Pubitemid 29512665)
67. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Fujiyama Y: Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70. (Pubitemid 36020767)
68. Abraham C, Cho JH: IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med 2008, Epub ahead of print.
69. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium: Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmune variants. Nat Genet 2007; 39: 1329-1337.
70. Barrett JC, Hansoul S, Nicolae DL, et al: Genome- wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40: 955-962.
71. Franke A, Balschun T, Karlsen TH, et al: Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 2008; 40: 713-715. (Pubitemid 351748866)
72. Anderson CA, Massey DCO, Barrett JC, et al: Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009; 136: 523-529.
73. Franke A, Balschun T, Karlsen TH, et al: Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008; 40: 1319-1323.
74. Fisher SA, Tremelling M, Anderson CA, et al: Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008; 40: 710-712. (Pubitemid 351748865)
75. Silverberg MS, Cho JH, Rioux JD, et al: Ulcerative colitis-risk loci on chromosome 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009; 41: 216-220.
76. Grundtner P, Gruber S, Murray SS, Vermeire S, Rutgeerts P, Decker T, Lakatos PL, Gasche C: The IL-10R1 S138G loss-of-function allele and ulcerative colitis. Genes Immun 2009; 10: 84-92.
77. Kugathasan S, Loizides A, Babusukumar U, McGuire E, Wang T, Hooper P, Nebel J, Kofman G, Noel R, Rudolph CD, Tolia V: Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and white children with Crohn's disease. Inflamm Bowel Dis 2005; 11: 631-638.
78. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Ogura Y, Inohara N, Nuñez G, Kishi Y, Koike Y, Shimosegawa T, Shimoyama T, Hibi T: Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86-91. (Pubitemid 34747528)
79. Leong RWL, Lau JY, Sung JYJ: The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004; 10: 646-651. (Pubitemid 39276475)
80. Cordell HJ, Clayton DG: Genetic association studies. Lancet 2005; 366: 1121-1131.
81. Achkar JP, Fiocchi C: Gene-gene interactions in inflammatory bowel disease: biological and clinical implications. Am J Gastroenterol 2009, in press.
82. Lawrance IC, Fiocchi C, Chakravarti S: Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001; 10: 445-456. (Pubitemid 32181667)
83. Wu F, Chakravarti S: Differential expression of inflammatory and fibrogenic genes and their regulation by NF-κB inhibition in a mouse model of chronic colitis. J Immunol 2007; 179: 6988-7000.
84. Sotiriou C, Pusztai L: Molecular origins of cancer: gene-expression signatures n breast cancer. N Engl J Med 2009; 360: 790-800.
85. Evans WE, McLeod HL: Pharmacogenomics: drug disposition, drug targets, and side effects. N Engl J Med 2003; 248: 538-549. (Pubitemid 36159890)